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Abstract
Objective: To evaluate the role of fractioned CO2 laser 
intravaginal as a non-invasive treatment for relieving stress 
urinary incontinence (SUI) symptoms.
Methods: This was a prospective, quasi-experimental study 
in patients with SUI. The patients were treated through three 
different sessions in a month apart by the fractioned CO2 laser 
Femilift©, produced by Alma Lasers. The patients fi lled and 
completed questionnaires about continence assessment, 
quality of life, and sexuality before and after therapy based 
on PISQ-12 and ICIQ-UI questionnaire. Perineometry was 
performed to prove the outcome. 
Results: Twenty women were enrolled. At 4 weeks following 
the third treatment, there was a signifi cant improvement 
for continence assessment (7.70 ± 4.38 to 4.50 ± 2.88; p < 
0.001), quality of life and sexuality (28.13 ± 7.06 to 33.13 
±7.80; p < 0.001), and vaginal perineometer results (37.20 ± 
17.24 to 48.80 ± 16.72; p = 0.009).
Conclusions: Fractioned CO2 intravaginal laser has a role in 
improving SUI symptoms.
Keywords: fractioned CO2 laser, stress urinary incontinence, 
vaginal rejuvenation.
Abstrak
Tujuan: Untuk mengetahui efektivitas terapi laser CO2 
terfraksi intravaginal sebagai terapi non-invasif untuk 
mengurangi gejala inkontinensia urine (IU) tipe tekanan.
Metode: Penelitian ini merupakan studi prospektif, quasi-
eksperimental pada pasien dengan inkontinensia urin (IU) 
tipe tekanan yang mengikuti terapi laser CO2 terfraksi 
intravaginal tiga sesi berbeda, dengan jarak satu bulan 
menggunakan laser CO2 terfraksi Femilift© dari Alma Lasers. 
Subjek mengisi kuesioner mengenai penilaian kontinensia, 
kualitas hidup dan kehidupan seksual sebelum dan sesudah 
terapi (kuesioner PISQ-12 dan ICIQ-UI). Selain kuesioner, 
pemeriksaan perineometri juga dilakukan pada beberapa 
subjek penelitian untuk membuktikan efektivitas terapi.
Hasil: Dua puluh subjek ikut dalam penelitian ini. 
Penilaian pada minggu keempat setelah sesi terapi ketiga, 
menunjukkan peningkatan yang signifi kan pada penilaian 
kontinensia (7.70 ± 4.38 ke 4.50 ± 2.88; p < 0.001), pada 
kualitas hidup dan kehidupan seksual (28.13 ± 7.06 ke 33.13 
±7.80; p < 0.001), dan pada hasil perineometri (37.20 ± 
17.24 ke 48.80 ± 16.72; p = 0.009).
Kesimpulan: Terapi laser CO2 terfraksi intravaginal 
menunjukkan kecenderungan untuk mengurangi gejala 
inkontinensia urine (IU) tipe tekanan.
Kata kunci: inkontinensia urin tipe tekanan, terapi laser CO2 
terfraksi intravaginal, vaginal rejuvenation.
INTRODUCTION
Stress Urinary Incontinence (SUI) is defi ned 
as involuntary urine leakage caused by the loss 
of urethral support, usually as a consequence of 
the supporting structural muscles in the pelvis.1,2 
It directly implicates to deterioration on quality 
of life.  In SUI, patients usually report leakage 
of small amount of urine during activities that 
increase abdominal pressure such as coughing, 
sneezing, and lifting of heavyweights.1-4
One of alternative treatment of SUI is 
through laser. This option has been reported to 
stimulate collagen neogenesis, skin and tissue 
remodelling, also rejuvenation in wound healing, 
dermatological and gynecological applications.5-9 
When recruiting this technology for intravaginal 
gynecological treatments, it is expected to 
exploit natural healing responses to trigger 
epithelial tissue regeneration to strengthen 
urethral support. The treatment exploits a unique 
combination of minimal superfi cial ablation and 
deeper thermal deposition of the fractioned CO2 
laser energy, delivered via a probe designed 
specifi cally for the vaginal anatomy. In response, 
it causes collagen and elastic fi ber remodelling, 
glycogen synthesis and transudate production 
yielding a state typical of the reproductive age.10
This prospective study aims to evaluate the 
effectiveness of fractioned CO2 laser intravaginal 
treatment in SUI patients.
METHODS
This was a prospective, quasi-experimental 
study, which was performed in YPK Mandiri 
Hospital. Women diagnosed with SUI were 
asked to participate in this study and signed the 
informed consent unless they refused. Patients 
were treated with three different sessions, 1 
month apart by the fractional CO2 laser Femilift© 
sponsored by Alma Lasers. Patients were fi lled the 
standardized questionnaire from ICIQ – IQ and 
PISQ – 12 in Bahasa to evaluate the effectiveness 
of fractioned CO2 laser treatment before and 
Progressive improvements before and after 
the treatment regiments were reported in 
Table 2. We observed a statistically signifi cant 
improvement in ICIQ – IU score, PISQ-12 score 
and in perineometers.
after 1 month of last therapy. They completed 
questionnaires about continence assessment, 
quality of life and sexuality. To prove objectively, 
the independent OB-GYN evaluated a vaginal 
perineometry.
The result was shown descriptively through 
frequency and percentage or mean (SD) for 
normal distribution and median (minimum-
maximum) for abnormal distribution. The 
analysis used paired t-test in SPSS version 23 for 
Mac. This study has been approved by the Ethical 
Research Committee of the Faculty of Medicine 
University of Indonesia under number 389/UN2.
F1/ETIK/2017.
RESULTS
There were 20 subjects included with the 
mean age of 54,95 ± 9,30 years old. Demographic 
characteristics were depicted in Table 1. 
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Table 2. Treatment Results before and after the Regiments














Table 1. Characteristics of the Subjects
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All patients completed ICIQ-UI questionnaire 
and there was a signifi cant difference before 
and after treatment. Sixteen patients fi lled in 
PISQ-12 questionnaire (4 patients were not 
sexual active) and there was statistically different 
between groups. Perineometers were also done 
to objectively observe the difference before 
and after the treatment regiments, but only 5 
patients agreed to do the test, and we also got 
a statistically signifi cant difference between the 
groups. 
DISCUSSION
Currently, there are many initial nonsurgical 
therapies for patients with SUI, such as 
behavioural therapy, pelvic fl oor muscle exercises, 
electric stimulation, vaginal cones, occlusive 
and intravaginal devices and pharmacological 
treatments. However, these strategies require 
the patient to show patience, motivation, and 
time commitment and undergo training. Women 
are unlikely to comply with a strict program 
of behaviour modifi cation and regular pelvic 
fl oor exercises.12 Therefore, other non-invasive 
methods are still urgently required and one of the 
instruments is fractioned CO2 laser intravaginal.
Previous studies have shown molecular 
changes and collagen synthesis in the atrophic 
vagina after fractional CO2 treatment.9,10,13,14 The 
biostimulative effect of fractioned CO2 laser 
treatment restores most vaginal functions, 
including secretion, absorption, elasticity and 
lubrication, and the thickness of the vaginal 
epithelium.15 The production of elastic fi bres and 
stimulation of neocollagenesis, that leads to the 
increased thickness of the vaginal epithelium may 
be related to the restoration of urethral coaptation 
mechanisms involved in the pathophysiology of 
SUI.14,15This cascade of events provides relief from 
discomfort in menopausal women.
Recent pilot studies have shown remarkable 
improvement in SUI after laser energy treatment 
including recovery of the submucosal blood 
vessel plexus and an increase in periurethral 
muscle tone that is related to the urethral closure 
pressure mechanism.14,15
These preliminary results warrant further 
assessments in a bigger sample size and over a 
longer follow – up period, later to be followed by 
validation in randomized studies. These studies 
must consider the longevity of both subjective 
and objective improvements, as well as the need 
for maintenance treatments.
CONCLUSION
Our preliminary results suggest that fractioned 
CO2 intravaginal laser has a role in improving 
symptoms in mild SUI patients. Fractioned CO2 
intravaginal laser is a minimally invasive tool, 
which provides for a novel approach to treat SUI 
symptoms. 
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